Literature DB >> 33813931

Considering Needle Phobia among Adult Patients During Mass COVID-19 Vaccinations.

Ashley S Love1, Robert J Love2.   

Abstract

As mass vaccination is underway to combat the COVID-19 pandemic and achieve herd immunity, healthcare professionals need to recognize the fear and phobia of needles among their patients. Approximately 11.5 to 66 million U.S. adults may suffer from this condition. This population often avoids seeking medical care including vaccinations. The exact number of people suffering from this phobia is unknown, and the potential years of life lost in the American health care system cannot be estimated accurately. The resistance to vaccinations among this population may delay achieving herd immunity to end this current pandemic. An overview of needle phobia, vaccinations, and current treatments are explored. The use of telemedicine could prove critical for reaching this population as well as those who are hesitant about vaccinations. Providing education to healthcare providers to identify and manage these patients during the pandemic is necessary.

Entities:  

Keywords:  COVID-19; blood-injection-injury; education; herd immunity; needle fear; needle phobia; pandemic; telemedicine; vaccinations

Year:  2021        PMID: 33813931     DOI: 10.1177/21501327211007393

Source DB:  PubMed          Journal:  J Prim Care Community Health        ISSN: 2150-1319


  3 in total

Review 1.  COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers-a review.

Authors:  Ebrahim Payberah; Daniel Payberah; Ashish Sarangi; Jayasudha Gude
Journal:  J Egypt Public Health Assoc       Date:  2022-01-21

2.  Advances in subcutaneous injections: PRECISE II: a study of safety and subject preference for an innovative needle-free injection system.

Authors:  E Lynne Kelley; Richard H Smith; Gillian Corcoran; Sandra Nygren; Mary V Jacoski; Andrea Fernandes
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

3.  Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.

Authors:  Brandi T Johnson-Weaver; Hae Woong Choi; Hang Yang; Josh A Granek; Cliburn Chan; Soman N Abraham; Herman F Staats
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.